Semaglutide.the GLP-1 standard, with two decades of trial data
One receptor. Two decades of receipts.
Semaglutide put GLP-1 on the map. Two decades of trial data, the first FDA-approved chronic weight-management peptide, and the most studied compound in the catalog. Our role is simple — ship the same molecule with a COA that proves it.
GLP-1 receptor
Activation slows gastric emptying, suppresses appetite at the hypothalamic level, and improves insulin response — the three-way mechanism behind every GLP-1 outcome paper.
Albumin binding
A C-18 fatty acid side chain binds serum albumin, extending half-life to ~7 days. The engineering choice that made once-weekly GLP-1 dosing practical.
Trial pedigree
STEP, SUSTAIN and SELECT generated the metabolic and cardiovascular data that made GLP-1 mainstream. Every newer agonist is benchmarked against semaglutide.
Trial-aligned titration ladder.
This is the published Phase 2 escalation pattern, not a dosing recommendation. Adjust under qualified guidance based on tolerability and research goals. Open the dosing calculator below to convert mg to units.
Onboarding dose. Establishes tolerance before titrating up.
First step. Some patients stabilize here if 1.0+ becomes intolerable.
The most-cited maintenance dose for sub-clinical protocols.
Trial-aligned maintenance. Higher doses correspond to deeper trial-published outcomes.
The complete research kit.
Every Element MD box ships with everything needed to reconstitute and run the protocol. We don't fragment the workflow into upsells — the kit is the kit.
- 01 Semaglutide vial5mg lyophilized peptide, sealed under inert gas×1
- 02 Bacteriostatic water0.9% benzyl alcohol, sterile, USP-grade3 mL
- 03 Insulin syringes30G ½", 0.5mL, individually sealed×10
- 04 Alcohol prep pads70% isopropyl, single-use×20
- 05 Sharps container1L, FDA-cleared, mail-back disposal label×1
- 06 Printed COA cardBatch-specific, signed by Janoshik Analytical×1
Patients logging Semaglutide data.
Every review below is tied to a verified order. We pull starting weight, current week, and dose so you can see the protocol behind each result, not just a star rating.
Titrated 0.25 → 1.0 over 12 weeks. Down 11.4% with no protocol stops. The Element MD COA matched what I expected from the molecule. No compounding-pharmacy variability.
Same dose, completely different consistency. The cap was tight, the powder uniform, the lab report on top.
Cross-tested at my own contract lab. 99.85% vs 99.87% on the supplied COA. Genuine quality.
Element MD is the one whose batch consistency I have not had to question. Reorder is automated and the COA on top of every box matches the database.
This vial's certificate, not a generic spec sheet.
Every batch ships with a signed COA from Janoshik Analytical. Open the original PDF, view the chromatogram, or look up any batch you've ever ordered.
Certificate of AnalysisJanoshik Analytical · Lab Report
2026-04-21
★ Verified ★
Pair Semaglutide with the rest of the protocol.
Common companions for Semaglutide research: complementary mechanisms that patients have stacked alongside this molecule, with shared QC and bundled subscription savings.
